Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Postal Ballot Notice

 This is further to our letter Ref: IMCL/CS/Postal Ballot/2021 dated 23rd June, 2021, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of the newspaper advertisements, regarding Postal Ballot Notice/Electronic Voting, published in the columns of English daily 'Financial Express' and Hindi daily 'Jansatta' on 26th June, 2021. This is for your information and record.
26-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st July, 2021 till 48 hours after the declaration of unaudited financial results for the quarter ending 30th June, 2021. The date of the Board Meeting to consider the unaudited financial results for the quarter ending 30th June, 2021, shall be intimated separately.
26-06-2021
Bigul

Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window

 Pursuant to the provisions of the Code of Conduct for Prevention of Insider Trading, under SEBI (Prohibition of Insider Trading) Regulations, 2015, it is hereby informed that Trading Window for dealing in shares of the Company, will remain closed with effect from 1st July, 2021 till 48 hours after the declaration of unaudited financial results for the quarter ending 30th June, 2021. The date of the Board Meeting to consider the unaudited financial results for the quarter ending 30th June, 2021, shall be intimated separately.
26-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

 We enclose a copy of the Postal Ballot Notice for seeking approval of its shareholders by way of Postal Ballot voting (only through e-voting) for the businesses as set out in the Postal Ballot notice dated 9th June, 2021. Postal Ballot Notice is being sent by e-mail only to those shareholders who have registered their e-mail addresses with the Company's Registrar and Share Transfer Agent or their respective Depository Participants as on Friday, 11th June, 2021 (cut-off date). Hard copy of Postal Ballot Notice along with Postal Ballot Forms and pre-paid business envelop will not be sent to the shareholders. The Company has engaged the services of NSDL for the purpose of providing e-voting facility to all its members. The voting through e-voting will commence from Thursday, 24th June, 2021 (9:00 A.M.) and shall end on Friday, 23rd July, 2021 (5:00 P.M.) The results of the postal ballot will be announced on Saturday, 24th July, 2021.
23-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Disclosure Of Related Party Trasnactions

 Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended 31st March, 2021.
19-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate

 This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor. 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director' from the Board of Directors of the Company. 3. Appointed Ms. Madhumita Ganguli (DIN : 00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to 8th June, 2026, subject to the approval of the shareholders of the Company. Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.
09-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Audited Financial Results For The Quarter And Year Ended 31-03-2021

 This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor. 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director' from the Board of Directors of the Company. 3. Appointed Ms. Madhumita Ganguli (DIN : 00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to 8th June, 2026, subject to the approval of the shareholders of the Company. Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.
09-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Outcome Of The Board Meeting

 This is to inform that the Board of Directors of the Company has, at its meeting held on Wednesday, 9th June, 2021 (i.e. today), inter-alia, considered and approved the following items: 1. Considered and approved the Audited Financial Results for the quarter and financial year ended March 31, 2021, along with the audit report of the statutory auditor. 2. Noted the resignation of Ms. Madhumita Ganguli (DIN : 00676830) as 'Non-Executive Non-Independent Director' from the Board of Directors of the Company. 3. Appointed Ms. Madhumita Ganguli (DIN : 00676830) as Independent Director of the Company, for a period of 5 consecutive years effective from 9th June, 2021 to 8th June, 2026, subject to the approval of the shareholders of the Company. Further, we wish to inform you that due to the impact of COVID-19 and uncertainty of growth in business, dividend on shares for the year 2020-21, has not been recommended by the Board.
09-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Intimation for Audited Financial Results For The Year Ended 31St March, 2021

 INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 9th June, 2021, inter alia to consider and approve, the audited financial results for the quarter/ year ended 31st March, 2021.
01-06-2021
Bigul

INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we hereby submit Annual Secretarial Compliance Report from a practicing Company Secretary, for the year ended 31st March, 2021. This is for your information and record.
15-05-2021
Next Page
Close

Let's Open Free Demat Account